Briobacept - CAS 869881-54-9

Briobacept (BR 3FC), a selective human monoclonal antibody, targets BLyS (BAFF) to induce B-cell apoptosis and is a recombinant glycoprotein comprising two BLyS receptor (BR3) molecules fused to the Fc domain of human IgG1. It has applications in the study of rheumatoid arthritis (RA) [1] [2].

ADC Antibody

Antibody-drug Conjugate/ADC Related

869818

-20°C

Ice Packs

Inhibitory Antibodies